Measles Virus as an Oncolytic Immunotherapy

Por Engeland, Christine E., Ungerechts, Guy
Publicado no Cancers (Basel) (2021)

Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies

Por Heidbuechel, Johannes P. W., Engeland, Christine E.
Publicado no J Hematol Oncol (2021)

The Cellular Protein Lyric Interacts with HIV-1 Gag

Por Engeland, Christine E., Oberwinkler, Heike, Schümann, Michael, Krause, Eberhard, Müller, Gerd A., Kräusslich, Hans-Georg
Publicado em 2011

Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors

Por Reul, Johanna, Frisch, Janina, Engeland, Christine E., Thalheimer, Frederic B., Hartmann, Jessica, Ungerechts, Guy, Buchholz, Christian J.
Publicado no Front Oncol (2019)

Fighting Cancer with Mathematics and Viruses

Por Santiago, Daniel N., Heidbuechel, Johannes P. W., Kandell, Wendy M., Walker, Rachel, Djeu, Julie, Engeland, Christine E., Abate-Daga, Daniel, Enderling, Heiko
Publicado no Viruses (2017)

Granulocyte-Macrophage Colony-Stimulating Factor-Armed Oncolytic Measles Virus Is an Effective Therapeutic Cancer Vaccine

Por Grossardt, Christian, Engeland, Christine E., Bossow, Sascha, Halama, Niels, Zaoui, Karim, Leber, Mathias F., Springfeld, Christoph, Jaeger, Dirk, von Kalle, Christof, Ungerechts, Guy
Publicado em 2013

Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation

Por Veinalde, Rūta, Grossardt, Christian, Hartmann, Laura, Bourgeois-Daigneault, Marie-Claude, Bell, John C., Jäger, Dirk, von Kalle, Christof, Ungerechts, Guy, Engeland, Christine E.
Publicado no Oncoimmunology (2017)

Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists

Por Backhaus, Paul S., Veinalde, Rūta, Hartmann, Laura, Dunder, Jessica E., Jeworowski, Lara M., Albert, Jessica, Hoyler, Birgit, Poth, Tanja, Jäger, Dirk, Ungerechts, Guy, Engeland, Christine E.
Publicado no Viruses (2019)

CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy

Por Engeland, Christine E, Grossardt, Christian, Veinalde, Rūta, Bossow, Sascha, Lutz, Diana, Kaufmann, Johanna K, Shevchenko, Ivan, Umansky, Viktor, Nettelbeck, Dirk M, Weichert, Wilko, Jäger, Dirk, von Kalle, Christof, Ungerechts, Guy
Publicado no Mol Ther (2014)

Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites

Por Leber, Mathias Felix, Baertsch, Marc-Andrea, Anker, Sophie Caroline, Henkel, Luisa, Singh, Hans Martin, Bossow, Sascha, Engeland, Christine E., Barkley, Russell, Hoyler, Birgit, Albert, Jessica, Springfeld, Christoph, Jäger, Dirk, von Kalle, Christof, Ungerechts, Guy
Publicado no Mol Ther Oncolytics (2018)

Measles Vaccines Designed for Enhanced CD8(+) T Cell Activation

Por Busch, Elena, Kubon, Kristina D., Mayer, Johanna K. M., Pidelaserra-Martí, Gemma, Albert, Jessica, Hoyler, Birgit, Heidbuechel, Johannes P. W., Stephenson, Kyle B., Lichty, Brian D., Osen, Wolfram, Eichmüller, Stefan B., Jäger, Dirk, Ungerechts, Guy, Engeland, Christine E.
Publicado no Viruses (2020)

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvO...

Por Hajda, Jacek, Lehmann, Monika, Krebs, Ottheinz, Kieser, Meinhard, Geletneky, Karsten, Jäger, Dirk, Dahm, Michael, Huber, Bernard, Schöning, Tilman, Sedlaczek, Oliver, Stenzinger, Albrecht, Halama, Niels, Daniel, Volker, Leuchs, Barbara, Angelova, Assia, Rommelaere, Jean, Engeland, Christine E., Springfeld, Christoph, Ungerechts, Guy
Publicado no BMC Cancer (2017)